Gilead Sciences
GILD
#131
Rank
A$230.11 B
Marketcap
A$185.34
Share price
-0.82%
Change (1 day)
6.12%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): A$11.09

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is A$10.56. In 2025 the company made an earnings per share (EPS) of A$9.75 an increase over its 2024 EPS that were of A$0.54.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$11.0913.75%
2025A$9.751702.63%
2024A$0.54-91.65%
2023A$6.4823.98%
2022A$5.22-25.86%
2021A$7.054850%
2020A$0.14-97.64%
2019A$6.040.9%
2018A$5.9818.71%
2017A$5.04-64.88%
2016A$14.35-18.45%
2015A$17.5955.28%
2014A$11.33296.02%
2013A$2.8617.89%
2012A$2.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.43 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.86-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.93-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$40.18 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.61 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$13.31 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$7.87-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$24.21 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.09-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA